JANE STREET GROUP, LLC - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 1 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$3,364
+12.1%
52,6490.0%0.00%
Q3 2022$3,000
-40.0%
52,6490.0%0.00%
Q2 2022$5,000
-61.5%
52,649
+0.6%
0.00%
Q1 2022$13,000
-61.8%
52,311
+0.7%
0.00%
Q4 2021$34,000
+3.0%
51,938
+3.9%
0.00%
Q3 2021$33,000
-25.0%
50,000
-1.7%
0.00%
Q2 2021$44,000
+46.7%
50,887
+1.8%
0.00%
Q1 2021$30,00050,0000.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2023
NameSharesValueWeighting ↓
RAMIUS ADVISORS LLC 501,826$432,0000.16%
Kingstown Capital 300,000$258,0000.15%
Telemetry Investments, L.L.C. 85,000$73,0000.10%
Corbin Capital Partners, L.P. 464,062$399,0000.08%
Atalaya Capital Management LP 278,437$239,0000.06%
Radcliffe Capital Management, L.P. 202,950$1,963,0000.06%
Kamunting Street Capital Management, L.P. 158,962$137,0000.06%
DG Capital Management, LLC 224,999$193,0000.04%
MMCAP International Inc. SPC 300,000$258,0000.01%
PERISCOPE CAPITAL INC. 248,300$213,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders